Peering into the aftermath: The inhospitable host?
- 1 October 2010
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 16 (10) , 1084-1085
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitmentProceedings of the National Academy of Sciences, 2010
- Pharmacokinetic/Pharmacodynamic Modeling of Biomarker Response to Sunitinib in Healthy VolunteersClinical Pharmacology & Therapeutics, 2010
- Plasma Cytokine and Angiogenic Factor Profiling Identifies Markers Associated with Tumor Shrinkage in Early-Stage Non–Small Cell Lung Cancer Patients Treated with PazopanibCancer Research, 2010
- Biomarkers of angiogenesis and their role in the development of VEGF inhibitorsBritish Journal of Cancer, 2009
- Biomarkers of response and resistance to antiangiogenic therapyNature Reviews Clinical Oncology, 2009
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor AngiogenesisCancer Cell, 2009
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacyProceedings of the National Academy of Sciences, 2007
- Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteinsJournal of Translational Medicine, 2007